Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Clin Orthop Relat Res ; (433): 258-64, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15805966

ABSTRACT

The aim of this study was to investigate whether all sizes of wear particles are capable of provoking inflammatory responses and whether there are different responses among different particle sizes. The knees of 40 female Balb/c mice were injected with polystyrene particles of three different diameters, 0.5 microm, 2.0 microm, and 75 microm, using a 0.1% vol/vol concentration. Seven days after particle injection, assessment of the synovial microcirculation using intravital microscopy, and histologic examination, were done. All the mice injected with polystyrene particles had enhanced leukocyte-endothelial cell interactions and histologic scores regardless of particle size when compared with control animals injected with sterile phosphate buffered saline. Polystyrene particles 0.5 microm in size provoked stronger membrane thickening and increased leukocyte-endothelial cell interactions than 75-microm particles. The fraction of rolling leukocytes was enhanced in the 2.0-microm particle group when compared with the 75-microm particle group. These results indicate that polystyrene particles of all sizes (0.5 microm, 2.0 microm, and 75 microm) are capable of inducing an inflammatory response. Small particles (0.5 microm, 2.0 microm) seem to provoke a stronger inflammatory response than larger particles (75 microm) in conditions with equal particle volume.


Subject(s)
Knee Joint/pathology , Polystyrenes/pharmacology , Synovial Membrane/drug effects , Synovitis/pathology , Animals , Disease Models, Animal , Female , Mice , Mice, Inbred BALB C , Microscopy, Electron , Particle Size , Probability , Reference Values , Sensitivity and Specificity , Synovial Membrane/pathology , Synovial Membrane/ultrastructure
2.
Clin Exp Rheumatol ; 23(1): 63-70, 2005.
Article in English | MEDLINE | ID: mdl-15789889

ABSTRACT

OBJECTIVE: There is controversy about the effects of cyclooxygenase-2 (COX-2) on adhesion molecules and the microvasculature in inflamed tissue. Thus, the aim of this study was to assess COX-2-expression in Antigen-induced Arthritis (AiA) and to investigate the effects of selective COX-2 inhibition by Celecoxib (4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] benzenesulfonamide) (CXB), on synovial microcirculation and adhesion molecule expression in arthritic as well as healthy mice. METHODS: Balb/c mice were allocated to 4 groups; 2 control groups with saline or CXB and 2 groups with AiA which also received saline or CXB (30 mg/kg BW in 0.3 ml solution). The severity of arthritis was assessed by changes in the transverse joint diameter On day 14 after AiA-induction, the patella tendon of the left knee joint was microsurgically resected and intravital fluorescence microscopy on synovial tissue was performed. Finally, the knee joint was removed for histology and immunohistochmistry. RESULTS: COX-2-expression in the inflamed synovium was demonstrated by immunohistochemistry. Application of Celecoxib resulted in a significant reduction in the rolling leukocyte fraction as well as in the number of leukocytes adherent to the endothelium (0.25 +/- 0. 1 and 96 +/- 34 cells/mm2 respectively) in comparison to the untreated animals with AiA (0.44 +/- 0.03 and 206 +/- 22 cells/mm2 respectively). Additionally, CXB-treated arthritic animals showed significantly less knee joint swelling and reduced adhesion molecule expression. CONCLUSION: In the present study, COX-2 expression in the synovial tissue of mice with AiA could be demonstrated. Selective COX-2 inhibition with CXB resulted in reduced leucocyte-endothelial cell interactions and decreased adhesion molecule expression. Evidence for a protective role of COX-2 in mouse AiA was not found.


Subject(s)
Arthritis/drug therapy , Cyclooxygenase Inhibitors/pharmacology , Pyrazoles/pharmacology , Sulfonamides/pharmacology , Synovial Membrane/drug effects , Animals , Antigens/adverse effects , Antigens/immunology , Arthritis/immunology , Celecoxib , Cell Adhesion Molecules/immunology , Cell Communication/immunology , Cyclooxygenase 2 , Cyclooxygenase 2 Inhibitors , Cyclooxygenase Inhibitors/immunology , Female , Inflammation/drug therapy , Mice , Mice, Inbred BALB C , Microcirculation/drug effects , Microcirculation/immunology , Models, Animal , Prostaglandin-Endoperoxide Synthases/immunology , Pyrazoles/immunology , Sulfonamides/immunology , Synovial Membrane/immunology
3.
Inflamm Res ; 52(5): 221-6, 2003 May.
Article in English | MEDLINE | ID: mdl-12813627

ABSTRACT

OBJECTIVE: To investigate the effects of ibandronate, a novel aminobisphosphonate, on inflammation as well as leukocyte-endothelial cell interaction in mouse antigen-induced arthritis (AiA). MATERIAL AND TREATMENT: 36 Balb/c mice were subcutaneously injected with 160 microg/kg of ibandronate once per day beginning at day 7 until day 13 after induction of AiA. METHODS: The severity of arthritis was assessed by changes of the transverse knee joint diameter. For the intravital fluorescence microscopy measurements on day 14 after AiA induction, the patella tendon was partly resected to visualize the intraarticular synovial tissue of the knee joint. The number of rolling and adherent leukocytes as well as red blood cell (RBC) velocity and functional capillary density (FCD) were quantified in synovial microvessels. Furthermore, leukocyte infiltration in the synovium was determined in histological sections with an established score. RESULTS: Both fractions of rolling leukocytes (p = 0.016) as well as number of extravasated leukocytes (p = 0.004) were enhanced in control animals treated with ibandronate in comparison to animals which received saline. Arthritic animals with and without ibandronate treatment revealed an increased FCD (p = 0.006, p = 0.008), enhanced number of rolling ( p = 0.002, p = 0.001) and adherent leukocytes (p = 0.009, p = 0.007) and greater swelling of the left knee joint (p = 0.002, p = 0.001) when compared to control animals. No significant differences between arthritic animals and arthritic animals treated with ibandronate were found in any of the parameters assessed including leukocyte adherence, FCD, histology, and knee joint swelling. CONCLUSION: Ibandronate treatment of healthy mice was associated with an enhanced fraction of rolling leukocytes and increased numbers of extravasated leukocytes indicating a proinflammatory effect on the synovial microcirculation. In animals with a preexisting antigen-induced arthritis, however, ibandronate did not induce an exacerbation of joint inflammation and leukocyte adherence.


Subject(s)
Anti-Inflammatory Agents , Arthritis, Experimental/prevention & control , Diphosphonates/pharmacology , Inflammation/prevention & control , Animals , Arthritis, Experimental/chemically induced , Diphosphonates/adverse effects , Endothelial Cells/drug effects , Female , Hemodynamics/drug effects , Ibandronic Acid , Inflammation/pathology , Joints/pathology , Leukocyte Count , Leukocytes/drug effects , Mice , Mice, Inbred BALB C , Microcirculation/drug effects , Serum Albumin, Bovine/immunology
4.
Orthopade ; 32(4): 305-11, 2003 Apr.
Article in German | MEDLINE | ID: mdl-12707694

ABSTRACT

Although it is now widely recognized that the inflammatory response to implant wear particles plays an important role in aseptic loosening of total joint replacements, the precise mechanisms of this process remain unclear. The aim of this study was to establish an animal model for the study of the adverse response to particulate wear debris and the effects on the synovial microcirculation as well as the leukocyte-endothelial cell interaction in the murine knee joint in vivo. Balb/c mice were injected with 50 microl of a 0.5-microm polystyrene particle suspension (0.1% v/v) into the knee joint. The severity of the inflammatory response was evaluated at days 1, 2, 3, 5, 7 (acute), 21 (intermediate), and 63 (chronic) after particle injection. Histological examination as well as assessment of the synovial microcirculation using intravital microscopy was performed. For the intravital microscopy measurements, the patella tendon was partially resected for visualization of the synovial tissue of the knee joint and the fluorescent markers FITC-dextran and rhodamine 6G were injected intravenously. There was a significantly enhanced leukocyte-endothelial cell interaction beginning at day 3 after particle injection with a maximum in the acute phase (days 5-7) and a subsequent decline in the intermediate (day 21) and chronic (day 63) phases. Functional capillary density was significantly increased from day 3 until day 21 after particle application. The histological examination showed an inflammatory reaction that complied widely with the temporal course of the microvascular parameters and resembled the histological appearance of the synovial-like membrane around loose joint prostheses. A novel model was established for the qualitative and quantitative investigation of the particle-induced inflammatory response in the joint environment. It was shown for the first time that there is a significantly enhanced leukocyte-endothelial cell interaction in the synovial tissue after intra-articular particle injection. This model seems to be suitable for further investigations, e.g., dealing with the biocompatibility of different particle materials.


Subject(s)
Equipment Failure Analysis , Foreign-Body Reaction/immunology , Knee Prosthesis , Materials Testing , Polystyrenes/toxicity , Synovitis/immunology , Animals , Disease Models, Animal , Endothelium, Vascular/immunology , Endothelium, Vascular/pathology , Female , Foreign-Body Reaction/pathology , Leukocytes/immunology , Leukocytes/pathology , Mice , Mice, Inbred BALB C , Microcirculation/immunology , Microcirculation/pathology , Particle Size , Synovial Membrane/blood supply , Synovial Membrane/pathology , Synovitis/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...